Taiwanese shares took a beating yesterday as the benchmark TAIEX fell to its lowest point in almost one year, as market worries remained over planned rate hikes by the US Federal Reserve, dealers said.
The bellwether electronics sector continued its downtrend, led by large-cap semiconductor stocks, while the financial sector saw a sell-off as investors rushed to downsize their portfolios amid market volatility, they said.
The TAIEX at its close was down 359.28 points, or 2.19 percent, at the day’s low of 16,048.92. Turnover totaled NT$239.82 billion (US$8.07 billion), with foreign institutional investors selling a net NT$21.15 billion of shares on the main board, Taiwan Stock Exchange (TWSE) data showed.
Photo by Sam Yeh / AFP
Yesterday’s closing level was the lowest since May 20 last year, when the TAIEX ended at 16,042.36, TWSE data showed.
“While US Federal Reserve Chair Jerome Powell has ruled out an increase of 75 basis points in each of the upcoming policymaking meetings, the rate hike cycle has been put in place, and many investors at home and abroad are increasingly worried about liquidity being drained from the market,” MasterLink Securities Corp (元富證券) analyst Tom Tang (湯忠謙) said.
The Fed raised its key interest rate by 50 basis points in a meeting held last week after a 25 basis point increase in March in an attempt to tackle inflation.
“In Taipei, investors stayed jittery about the US markets’ performance, so they simply scrambled to further unload their holdings. Today, massive selling was seen among financial stocks, having spread from their tech counterparts,” Tang said.
The financial sector closed down by 3.4 percent, and the electronics sector fell by 1.72 percent overall, with the semiconductor subindex declining by 1.78 percent, and the transportation sector, which includes major shipping and airline stocks, declined 3.53 percent, TWSE data showed.
“Today’s turnover remained low, as many investors were reluctant to buy during the dips since they fear more losses down the road,” Tang said. “The market also remains alert to the impact on the economy from COVID-19 lockdowns in China.”
This time was supposed to be different. The memorychip sector, famous for its boom-and-bust cycles, had changed its ways. A combination of more disciplined management and new markets for its products — including 5G technology and cloud services — would ensure that companies delivered more predictable earnings. Yet, less than a year after memory companies made such pronouncements, the US$160 billion industry is suffering one of its worst routs ever. There is a glut of the chips sitting in warehouses, customers are cutting orders and product prices have plunged. “The chip industry thought that suppliers were going to have better control,” said
Enimmune Corp (安特羅生技) has obtained marketing approval from the Food and Drug Administration (FDA) for its EnVAX-A71 vaccine for enterovirus 71 (EV-71), becoming the nation’s first enterovirus vaccine completely made in Taiwan, it said yesterday. After spending 13 years and NT$1.5 billion (US$49.77 million) on the research and development of the vaccine, Enimmune plans to start manufacturing and marketing it by the end of March, the company said in a statement, without disclosing customer order figures. “It is possible that the vaccine would not be included in a national vaccination program initially, and consumers would need to pay for it themselves,” parent
Vaccine skeptics blocking transfusions for life-saving surgeries, Facebook groups inciting violence against doctors and a global search for unvaccinated donors — COVID-19 misinformation has bred a so-called “pure blood” movement. The movement spins anti-vaccine narratives focused on unfounded claims that receiving blood from people inoculated against COVID-19 “contaminates” the body. Some have advocated for blood banks that draw from “pure” unvaccinated people, while medics in North America say they have fielded requests from people demanding transfusions from donors who have not received a vaccine. In closed social media groups, vaccine skeptics — who brand themselves as “pure bloods” — promote violence against doctors
Asteroid mining start-up AstroForge Inc is planning to launch its first two missions to space this year as it seeks to extract and refine metals from deep space. The first launch, scheduled for April, is to test AstroForge’s technique for refining platinum from a sample of asteroid-like material. The second, planned for October, would scout for an asteroid near Earth to mine. The missions are part of AstroForge’s goal of refining platinum-group metals from asteroids, with the aim of bringing down the cost of mining these metals. It also hopes to reduce the massive amount of carbon emissions that stem from mining
RSS